SG3 Management’s Medtronic MDT Stock Holding History

SG3 Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,000	Closed	-$591K	–	1200
2021 Q1	$591K	Sell	5,000 -45,000	-90%	-$5.27M	0.01%	731
2020 Q4	$5.86M	Buy	+50,000	New	+$5.5M	0.11%	169

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG3 Management's MDT Position: Q2 2022 in Review

SG3 Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 25,000 shares — an estimated $2.77M sold.

SG3 Management first reported a position in MDT in Q1 2020 and held it in 4 quarters. The position peaked at $2.77M in Q1 2022. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

SG3 Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 25,000 Medtronic shares in Q2 2022, an estimated $2.77M.
SG3 Management first reported a position in Medtronic in Q1 2020 and held it in 4 quarters.
SG3 Management's Medtronic position peaked at $2.77M in Q1 2022.
2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.